Strides Pharma gets USFDA nod for generic ointment to treat skin conditions

The approval is granted to the company#39;s step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2Att3Ib